Home › Funds › MPM BioImpact LLC › TRDA

MPM BioImpact LLC position in TRDA

ENTRADA THERAPEUTICS INC · Health Care

MPM BioImpact LLC reported holding 1,253,053 shares of TRDA (ENTRADA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.2M, representing 0.56% of its reported portfolio and ranking #34 among its reported holdings. MPM BioImpact LLC first reported this position in Q2 2026.

Latest position (Q2 2026)1.25M sh
Reported value held$9.22M
Portfolio Weight0.56%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's TRDA position evolved

MPM BioImpact LLC first disclosed a stake in TRDA in Q2 2026 at 1,253,053 shares (US$9.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.25M $9.22M New

About TRDA and 13F data

TRDA (ENTRADA THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in TRDA — the largest reported positions include BAKER BROS. ADVISORS LP (US$37.3M), 5AM Venture Management, LLC (US$29.9M), Merck & Co., Inc. (US$12.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRDA

All TRDA fund holders →

FAQ

How long has MPM BioImpact LLC held TRDA?

MPM BioImpact LLC has disclosed TRDA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is MPM BioImpact LLC's current position in TRDA?

As of Q2 2026, MPM BioImpact LLC holds 1.25M shares of TRDA (ENTRADA THERAPEUTICS INC), valued at $9.22M, representing 0.56% of its reported portfolio and ranking #34.

Has MPM BioImpact LLC been buying or selling TRDA?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC newly opened its position in TRDA.

Which other funds hold TRDA?

Other major institutional holders of TRDA include BAKER BROS. ADVISORS LP, 5AM Venture Management, LLC, Merck & Co., Inc., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.